vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and T1 Energy Inc. (TE). Click either name above to swap in a different company.

T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $121.8M, roughly 1.7× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -62.0%, a 66.2% gap on every dollar of revenue. T1 Energy Inc. produced more free cash flow last quarter ($55.0M vs $517.0K).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.

CLB vs TE — Head-to-Head

Bigger by revenue
TE
TE
1.7× larger
TE
$210.5M
$121.8M
CLB
Higher net margin
CLB
CLB
66.2% more per $
CLB
4.2%
-62.0%
TE
More free cash flow
TE
TE
$54.5M more FCF
TE
$55.0M
$517.0K
CLB

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CLB
CLB
TE
TE
Revenue
$121.8M
$210.5M
Net Profit
$5.1M
$-130.6M
Gross Margin
10.0%
Operating Margin
1.5%
-45.0%
Net Margin
4.2%
-62.0%
Revenue YoY
-1.4%
Net Profit YoY
-375.2%
EPS (diluted)
$0.11
$-0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
TE
TE
Q1 26
$121.8M
Q4 25
$138.3M
Q3 25
$134.5M
$210.5M
Q2 25
$130.2M
$132.8M
Q1 25
$123.6M
$53.5M
Q4 24
$129.2M
Q3 24
$134.4M
$0
Q2 24
$130.6M
$0
Net Profit
CLB
CLB
TE
TE
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$14.2M
$-130.6M
Q2 25
$10.6M
$-31.9M
Q1 25
$-154.0K
$-16.2M
Q4 24
$7.4M
Q3 24
$11.7M
$-27.5M
Q2 24
$9.0M
$-27.0M
Gross Margin
CLB
CLB
TE
TE
Q1 26
Q4 25
20.8%
Q3 25
22.0%
10.0%
Q2 25
20.3%
24.7%
Q1 25
19.5%
33.3%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
TE
TE
Q1 26
1.5%
Q4 25
11.5%
Q3 25
15.6%
-45.0%
Q2 25
11.7%
-22.0%
Q1 25
3.6%
-44.2%
Q4 24
11.0%
Q3 24
14.7%
Q2 24
12.3%
Net Margin
CLB
CLB
TE
TE
Q1 26
4.2%
Q4 25
3.6%
Q3 25
10.6%
-62.0%
Q2 25
8.2%
-24.0%
Q1 25
-0.1%
-30.4%
Q4 24
5.7%
Q3 24
8.7%
Q2 24
6.9%
EPS (diluted)
CLB
CLB
TE
TE
Q1 26
$0.11
Q4 25
$0.11
Q3 25
$0.30
$-0.87
Q2 25
$0.22
$-0.21
Q1 25
$0.00
$-0.11
Q4 24
$0.15
Q3 24
$0.25
$-0.20
Q2 24
$0.19
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
TE
TE
Cash + ST InvestmentsLiquidity on hand
$22.8M
$34.1M
Total DebtLower is stronger
$547.3M
Stockholders' EquityBook value
$275.1M
$96.9M
Total Assets
$587.7M
$1.4B
Debt / EquityLower = less leverage
5.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
TE
TE
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
$34.1M
Q2 25
$31.2M
$8.5M
Q1 25
$22.1M
$48.9M
Q4 24
$19.2M
Q3 24
$21.5M
$181.9M
Q2 24
$17.7M
$219.6M
Total Debt
CLB
CLB
TE
TE
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
$547.3M
Q2 25
$124.6M
$591.2M
Q1 25
$124.4M
$603.2M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
TE
TE
Q1 26
$275.1M
Q4 25
$266.0M
Q3 25
$271.3M
$96.9M
Q2 25
$261.3M
$183.9M
Q1 25
$253.4M
$201.9M
Q4 24
$246.6M
Q3 24
$250.7M
$538.7M
Q2 24
$240.3M
$561.6M
Total Assets
CLB
CLB
TE
TE
Q1 26
$587.7M
Q4 25
$584.0M
Q3 25
$591.4M
$1.4B
Q2 25
$602.1M
$1.4B
Q1 25
$591.5M
$1.4B
Q4 24
$585.1M
Q3 24
$600.5M
$615.0M
Q2 24
$597.8M
$644.4M
Debt / Equity
CLB
CLB
TE
TE
Q1 26
Q4 25
0.41×
Q3 25
0.42×
5.65×
Q2 25
0.48×
3.21×
Q1 25
0.49×
2.99×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
TE
TE
Operating Cash FlowLast quarter
$4.0M
$63.9M
Free Cash FlowOCF − Capex
$517.0K
$55.0M
FCF MarginFCF / Revenue
0.4%
26.1%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$-42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
TE
TE
Q1 26
$4.0M
Q4 25
$7.9M
Q3 25
$8.5M
$63.9M
Q2 25
$13.9M
$33.4M
Q1 25
$6.7M
$-44.8M
Q4 24
$20.6M
Q3 24
$13.1M
$-28.4M
Q2 24
$17.1M
$-28.0M
Free Cash Flow
CLB
CLB
TE
TE
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
$55.0M
Q2 25
$10.4M
$10.6M
Q1 25
$3.9M
$-74.0M
Q4 24
$17.4M
Q3 24
$10.4M
$-34.0M
Q2 24
$14.3M
$-35.6M
FCF Margin
CLB
CLB
TE
TE
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
26.1%
Q2 25
8.0%
8.0%
Q1 25
3.1%
-138.4%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
TE
TE
Q1 26
Q4 25
2.1%
Q3 25
1.5%
4.2%
Q2 25
2.7%
17.2%
Q1 25
2.3%
54.5%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
TE
TE
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

TE
TE

Related Party$120.1M57%
Nonrelated Party$90.4M43%

Related Comparisons